Avivo was one of five companies selected for funding under the Government of Canada’s Life Sciences Fund to advance dual-use innovations and strengthen Canada’s industrial capacity.
Catégorie : Success Stories
Glycomics in Action: Powering the Next Wave of Biotech Breakthroughs
In the most recent issue of BIOTECanada’s Insights Magazine, we talk about how Canada’s glycomics ecosystem is helping move complex sugar science from the lab into real-world solutions for health, biomanufacturing, and biosecurity.
Coup d’œil sur la science des sucres : faits saillants du Symposium Canadien sur la Glycomique 2026
Over 190 researchers, industry experts, and emerging talent in glycomics gathered for the 9th Canadian Glycomics Symposium, in Canmore, Alberta, May 12-14, 2026.
GlycoNet-Supported Startup Synakis Announces Close of Oversubscribed Pre-Seed Round
The CAD $2.6 million pre-seed financing round included support from GlycoNet’s Kickstart Program.
Le rôle des sucres dans l’avenir de la médecine et de l’agriculture
This article highlights some of the ways that Canadian researchers are using glycomics to drive medical breakthroughs and more sustainable
32nd International Carbohydrate Symposium
GlycoNet will be attending the 32nd International Carbohydrate Symposium (ICS 2026), taking place July 5–9, 2026, in Bratislava, Slovakia.
AdvanCell and GlycoNet-supported startup 48Hour Discovery announce collaboration and exclusive licensing agreement
48Hour Discovery partners with AdvanCell to advance a peptide-based Lead-212 radioligand therapy program for oncology.
Research Saves Lives
Dr. Lori West honoured by Heart and Stroke Foundation
GlycoNet startup Avivo achieves world’s first blood type A-to-O kidney transplant, a breakthrough for universal donor organs
The successful transplant marks major progress towards more compatible, accessible organs for patients.
La glycomique en pleine effervescence au cœur de Glyco27
Plus de 400 chercheurs, experts de l’industrie et jeunes talents en glycobiologie se sont réunis à Edmonton (Alberta), du 25 au 30 mai 2025, à l’occasion du 27ᵉ Symposium international sur les glycoconjugués (Glyco27), organisé conjointement avec le 8ᵉ Symposium canadien de glycomique.